Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030

Viking Therapeutics (VKTX 7.13%) doesn't have an approved product on the market yet. However, its market cap of around $5.2 billion underscores investors' excitement about Viking's pipeline. Believe it or not, we're nearly halfway through this decade. The healthcare sector could be in store for monumental changes over the next few years. 1. Vertex Pharmaceuticals I predict that Vertex will add three other blockbuster drugs that don't treat CF to its lineup by 2030. It seems likely to win U.S. approval of su ...